Understanding and coping with a new melanoma diagnosis, or melanoma recurrence, can be frightening and overwhelming.

AIM’s “Ask a Medical Expert” was created to help individuals understand their melanoma diagnosis, its implications, and how to approach and navigate their situation.

Melissa Wilson, PA-C, MPAS, leads AIM’s “Ask a Medical Expert” program and is AIM’s resident melanoma medical expert.  Wilson brings a wealth of knowledge and experience to the role, and boundless enthusiasm for the industry – and her patients.

A natural trailblazer, Wilson is proud of her collaborative work as an NCCPA-certified physician assistant senior since 2005 with the distinguished melanoma specialist Dr. John Kirkwood at the University of Pittsburgh in the Cancer Institute Division of Hematology/Oncology, Department of Medicine. Their treatment and research initiatives were so successful that they have been used as a template for other cancer programs throughout the country. Wilson works as lead physician assistant for the Melanoma Program at UPMC Hillman Cancer Center.

Su experiencia se centra en la atención aguda en oncología ambulatoria con pacientes de investigación y la población general de melanoma. Ayuda a los pacientes a gestionar los problemas y las urgencias relacionados con la toxicidad de la terapia. Tiene experiencia en biopsias y técnicas de sutura; crioterapia; inyecciones; revisiones de imágenes; seguimiento de ensayos clínicos; y mediciones tumorales RECIST.

Profesora por naturaleza, Wilson también ha trabajado con un equipo multidisciplinar en la educación y colaboración de los pacientes. Tiene nombramientos en la Chatham University Clinical Preceptor donde es profesora adjunta y es conferenciante de módulos de atención al cáncer sobre el melanoma desde 2013.

Inspirada en su carrera por la batalla de su propio padre contra el cáncer (¡se encuentra bien!), Wilson afirma que nunca dejará de querer ayudar a los pacientes a luchar contra el melanoma. También confía en que la cura está en el horizonte, dado que los tratamientos del melanoma han crecido exponencialmente en los últimos años.

Wilson es nativa de Pensilvania y tiene su maestría de la Universidad de Chatham en estudios de asistente médico (MPAS), y PA-C (certificado en Pensilvania).

Webinars de la clínica a la sala de estar

From the Clinic to the Living Room brings clarity to melanoma’s complexity, designed to help us all better understand melanoma.

Melissa Wilson, PA-C, MPAS, Melanoma Lead with UPMC Hillman Cancer Center and AIM at Melanoma Foundation’s medical expert, explores everything you need to know – from melanoma screening and prevention, how to handle a melanoma diagnosis, understanding one’s treatment options, and far, far more – all brought to you by AIM at Melanoma Foundation.

We also hope that Melissa’s new informational video series, Melanoma 101,” empowers you with a new understanding of melanoma that will inform and change your perspective on the disease.

2022 Webinars

REGISTRATION OPEN FOR Using ctDNA as a Biomarker for Melanoma

On Wednesday, October 19th, Melissa Wilson, PA-C, MPAS, welcomed Dr. Andrew S. Poklepovic for a 30-minute discussion about ctDNA.

Discussion topics included:

  • What is ctDNA?
  • How is this test performed?
  • What information can be gathered from this test?
  • How is this currently being utilized in melanoma?
  • How do you see this being used in the future with melanoma?

About our guest:

Dr. Poklepovic serves as assistant professor in the Division of Hematology, Oncology and Cuidados paliativos at the VCU Massey Cancer Center and is a Harrison Endowed Scholar at the VCU School of Medicine. He is also the medical director for the Massey Cancer Center Clinical Trials Office and an associate member of the Massey Cancer Center Developmental Therapeutics Program for the Department of Internal Medicine.

Dr. Poklepovic is a medical oncologist at Massey Cancer Center and practices at the Dalton Oncology Clinic and Stony Point Clinic. His research interests include melanoma, cutaneous oncology, squamous cell carcinoma, Merkel Cell Carcinoma, basal cell carcinoma, liver carcinoma, pancreatic cancer, breast cancer, and early-phase clinical trials.

He has co-authored more than 80 peer-reviewed publications and is a member of HCRN’s Melanoma Clinical Trial Working Group. Dr. Poklepovic gave an inspiring TedxRVA talk several years ago that highlights how advances in cancer research have led to transformative change in treatment options and outcomes for patients.

Educational Background:

  • Medical School: University of South Florida College of Medicine
  • Residency: VCU Medical Center, Internal Medicine, Chief Resident
  • Fellowship: VCU Medical Center, Hematology/Oncology

Para ver los anteriores seminarios web de formación de pacientes, haga clic AQUÍ.